This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ogata, S. Articles by Itzkowitz, S. H. Search for Related Content PubMed PubMed Citation Articles by Ogata, S. Articles by Itzkowitz, S. H.

Use of Model Cell Lines to Study the Biosynthesis and Biological Role of Cancer-associated Sialosyl-Tn Antigen¹

Department of Medicine, Gastrointestinal Research Laboratory, Mount Sinai School of Medicine, New York, New York 10029

Sialosyl-Tn (STn) is a mucin-associated carbohydrate antigen that is not expressed by most normal epithelial cells but becomes expressed in several types of adenocarcinomas, where it is often associated with a poor prognosis. Little is known about the regulation of the STn phenotype in tumor cells and the immune response to STn antigen. In the present study, we established clonal cell lines in which virtually all of the cells were STn positive (designated LS-C) or STn negative (designated LS-B). These two cell lines, derived from a single parental cell line, LS174T, have the same total protein electrophoretic profiles but carry markedly different oligosaccharide structures on their mucin; the mucin from LS-C cells has only the Tn and STn structures, whereas LS-B cell mucin lacks these simple structures but carries more complex oligosaccharides. These results indicate that lack of STn expression by cells can be due to the lack of STn synthesis rather than inaccessibility of antibodies to bind to STn by steric hindrance. Both clones were similar in their growth rates, response to -interferon, and sensitivity to lysis by lymphokine-activated killer cells. These cells may be important models for understanding the regulation of glycosylation at the cellular level and for further studies of tumor biology and immune response to STn antigen.

¹ Supported by USPHS/National Cancer Institute Grant CA-52491 and The Chemotherapy Foundation. S. H. I. is the recipient of an Irma T. Hirschl Career Scientist Award and a Charles Newman Scholarship.

² To whom requests for reprints should be addressed, at Division of Gastroenterology, Box 1069, Mount Sinai School of Medicine, 1 Gustave Levy Place, New York, NY 10029-6574.

Received 3/18/94. Accepted 6/ 1/94.

This article has been cited by other articles:

				T. Ju, G. S. Lanneau, T. Gautam, Y. Wang, B. Xia, S. R. Stowell, M. T. Willard, W. Wang, J. Y. Xia, R. E. Zuna, et al. Human Tumor Antigens Tn and Sialyl Tn Arise from Mutations in Cosmc Cancer Res., March 15, 2008; 68(6): 1636 - 1646. [Abstract] [Full Text] [PDF]

				T. A. Gilewski, G. Ragupathi, M. Dickler, S. Powell, S. Bhuta, K. Panageas, R. R. Koganty, J. Chin-Eng, C. Hudis, L. Norton, et al. Immunization of High-Risk Breast Cancer Patients with Clustered sTn-KLH Conjugate plus the Immunologic Adjuvant QS-21 Clin. Cancer Res., May 15, 2007; 13(10): 2977 - 2985. [Abstract] [Full Text] [PDF]

				G. Ragupathi, N. X. Liu, C. Musselli, S. Powell, K. Lloyd, and P. O. Livingston Antibodies against Tumor Cell Glycolipids and Proteins, but Not Mucins, Mediate Complement-Dependent Cytotoxicity J. Immunol., May 1, 2005; 174(9): 5706 - 5712. [Abstract] [Full Text] [PDF]

				M. Clement, J. Rocher, G. Loirand, and J. Le Pendu Expression of sialyl-Tn epitopes on {beta}1 integrin alters epithelial cell phenotype, proliferation and haptotaxis J. Cell Sci., October 1, 2004; 117(21): 5059 - 5069. [Abstract] [Full Text] [PDF]

				G. Ragupathi, D. M. Coltart, L. J. Williams, F. Koide, E. Kagan, J. Allen, C. Harris, P. W. Glunz, P. O. Livingston, and S. J. Danishefsky On the power of chemical synthesis: Immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines PNAS, October 15, 2002; 99(21): 13699 - 13704. [Abstract] [Full Text] [PDF]

				M. Meichenin, J. Rocher, O. Galanina, N. Bovin, N. Nifant’ev, A. Sherman, E. Cassagnau, M. F. Heymann, J. Bara, R. H. Fraser, et al. Tk, a New Colon Tumor-associated Antigen Resulting from Altered O-Glycosylation Cancer Res., October 1, 2000; 60(19): 5499 - 5507. [Abstract] [Full Text]